{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-353278","form_type":"8-K","ticker":"FULC","cik":"0001680581","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2026-08-17T12:30:07+00:00","discovered_at":"2026-08-17T12:35:00.454297+00:00","generated_at":"2026-08-17T12:35:58.858573+00:00","sec_items":["1.01","3.02","5.01","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Fulcrum to merge with Slate Medicines; Slate holders to own ~95% of combined company","bullets":["Merger values Slate at $350M, Fulcrum at $31.3M; post-close ownership: Slate holders ~55.9%, investors ~39.1%, Fulcrum ~5.0%.","$245M concurrent investment from existing Slate stockholders and new investors; combined cash runway into 2029.","Fulcrum to pay $270M cash dividend to pre-merger Fulcrum stockholders; company renamed Slate Medicines, Inc.","Fulcrum board set at 5 members, all designated by Slate; Fulcrum options with exercise price >$7.00 cancelled at close.","Termination fees: Fulcrum pays $10M, Slate pays $15M; Slate stockholders holding 78.65% support deal."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-353278","json":"https://secwatch.observer/filing/0001193125-26-353278.json","markdown":"https://secwatch.observer/filing/0001193125-26-353278.md","text":"https://secwatch.observer/filing/0001193125-26-353278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526353278/0001193125-26-353278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526353278/d136791d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T12:35:58.858573+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}